Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

Dual Antiplatelet Therapy for Acute Stroke and TIA: Current Best Practice and Emerging Strategies

Published: 09 November 2020

Views:
8855
Likes:
7

Views:
8855
Likes:
7
Share:

Now Playing
Part 3
Current Best Practice: Evidence-Based Antiplatelet Therapy for Secondary Stroke Prevention
Pierre Amarenco

Up Next

13m 46s

Part 4 Evolving Role of Dual Antiplatelet Therapy for Stroke Prevention: Advancing Best Practice for Patients at High Risk
Clay Johnston

15m 34s

Part 5 Clinical Decision Making for the Patient Presenting with Acute Stroke
Peter Schellinger

28m 37s

Part 6 Q&A and Summary
Pierre Amarenco, Peter Rothwell, Clay Johnston, Peter Schellinger

3m 16s

Part 1 Chairperson’s welcome and introduction Pierre Amarenco

15m 12s

Part 2 Secondary Prevention after Acute Minor Stroke or TIA: Understanding the Ongoing Risk Peter Rothwell

Average (ratings)

No ratings

Your rating

Overview

This educational symposium was first broadcast in the joint European Stroke Organisation and World Stroke Organization (ESO-WSO 2020) Virtual Conference held 7-9 November.

The programme focuses upon emerging data and best practice in the use of antiplatelet therapy for the treatment of Acute Stroke and TIA

The programme was supported by an unrestricted educational grant from AstraZeneca.

Learning Objectives

To Highlight the Continued High Unmet Need for Strategies to Prevent Stroke or Death for Patients Experiencing Acute Stroke or TIA
To Outline the Guidelines on the Use of Dual Antiplatelet Therapy for Patients Presenting with Acute Stroke or TIA
To Examine Recent Evidence from Clinical Trials on Novel Strategies for Improving Outcomes for Patients Presenting with Acute Stroke or TIA and How These Data and Insights Can Be Applied in Clinical Practice

More from this programme

Part 1

Chairperson’s Welcome and Introduction

1 session
Chairperson’s welcome and introduction	Watch now

Part 2

Secondary Prevention after Acute Minor Stroke or TIA: Understanding the Ongoing Risk

1 session
Secondary Prevention after Acute Minor Stroke or TIA: Understanding the Ongoing Risk	Watch now

Part 3

Current Best Practice: Evidence-Based Antiplatelet Therapy for Secondary Stroke Prevention

1 session
Current Best Practice: Evidence-Based Antiplatelet Therapy for Secondary Stroke Prevention	Watch now

Part 4

Evolving Role of Dual Antiplatelet Therapy for Stroke Prevention: Advancing Best Practice for Patients at High Risk

1 session
Evolving Role of Dual Antiplatelet Therapy for Stroke Prevention: Advancing Best Practice for Patients at High Risk	Watch now

Part 5

Clinical Decision Making for the Patient Presenting with Acute Stroke

1 session
Clinical Decision Making for the Patient Presenting with Acute Stroke	Watch now

Part 6

Q&A and Summary

1 session
Q&A and Summary	Watch now

Faculty Biographies

Pierre Amarenco

Pierre Amarenco

Pierre Amarenco is Professor of Neurology at Paris University, France. He also serves as Chair of the Department of Neurology and Stroke Center, and also of the SOS-TIA Clinic at Bichat University Hospital in Paris. He has published more than 450 original contributions, research papers, and reviews.

View full profile